These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25189036)

  • 1. [Statins and muscle pain].
    Yosef Y; Schurr D; Constantini N
    Harefuah; 2014 Jul; 153(7):423-7, 431. PubMed ID: 25189036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Muscle problems due to statins: underestimated].
    Janssen SP; Smulders YM; Gerdes VE; Visseren FL
    Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.
    van Staa TP; Carr DF; O'Meara H; McCann G; Pirmohamed M
    Br J Clin Pharmacol; 2014 Sep; 78(3):649-59. PubMed ID: 24602118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.
    Jacobson TA
    Mayo Clin Proc; 2008 Jun; 83(6):687-700. PubMed ID: 18533086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myalgia and statins: Separating the true from the false].
    Blacher J; Bruckert E; Farnier M; Ferrières J; Henry P; Krempf M; Mourad JJ
    Presse Med; 2019 Oct; 48(10):1059-1064. PubMed ID: 31473026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle toxicity with statins.
    Hedenmalm K; Alvan G; Ohagen P; Dahl ML
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of xanthine oxidase to prevent statin-induced myalgia and rhabdomiolysis.
    Alis R; Sanchis-Gomar F; Risso-Ballester J; Perez-Quilis C; Cortell-Ballester J; Romagnoli M; Blesa JR; Emanuele E
    Atherosclerosis; 2015 Mar; 239(1):38-42. PubMed ID: 25568951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing statin-induced muscle toxicity in a lipid clinic.
    Blaier O; Lishner M; Elis A
    J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin.
    Schindler C; Thorns M; Matschke K; Tugtekin SM; Kirch W
    Clin Ther; 2007 Jan; 29(1):172-6. PubMed ID: 17379057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-related adverse events: a meta-analysis.
    Silva MA; Swanson AC; Gandhi PJ; Tataronis GR
    Clin Ther; 2006 Jan; 28(1):26-35. PubMed ID: 16490577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotoxicity associated with lipid-lowering drugs.
    Baer AN; Wortmann RL
    Curr Opin Rheumatol; 2007 Jan; 19(1):67-73. PubMed ID: 17143099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise-induced myalgia may limit the cardiovascular benefits of statins.
    Opie LH
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):569-72. PubMed ID: 23934075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rhabdomyolysis related to statin and seizures: report of 3 cases].
    Guan YQ; Shi YJ; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1795-6. PubMed ID: 22027795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.
    Madeddu G; De Socio GV; Ricci E; Quirino T; Orofino G; Carenzi L; Franzetti M; Parruti G; Martinelli C; Vichi F; Penco G; Dentone C; Celesia BM; Maggi P; Libertone R; Bagella P; Di Biagio A; Bonfanti P;
    Int J Antimicrob Agents; 2015 Mar; 45(3):289-94. PubMed ID: 25476452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.